Core Viewpoint - Scotts Miracle-Gro Company is in advanced discussions to sell its Hawthorne subsidiary to Vireo Growth, Inc., with the deal expected to close in the second quarter of fiscal 2026 [1] Group 1: Sale of Hawthorne Subsidiary - The proposed terms involve Vireo Growth acquiring Hawthorne in exchange for an investment in Vireo, integrating cultivation supply into its consumer cannabis operations [1] Group 2: Financial Reporting and Guidance - The company has classified the Hawthorne business as a discontinued operation effective in the first quarter of fiscal 2026 and reaffirmed its fiscal 2026 guidance [2] - In the first quarter, the net loss from continuing operations was $47.8 million, an improvement from a loss of $66.1 million in the prior year, with loss per share from continuing operations at $0.83 compared to $1.15 [3] - Adjusted net loss per common share from continuing operations was $0.77, down from $0.88 a year ago, while net sales were $354.4 million, reflecting a 3% decrease [3] Group 3: Share Repurchase Program - The Board has approved a share repurchase program authorizing the repurchase of up to $500 million of Scotts Miracle-Gro common stock [2] Group 4: Market Reaction - In pre-market trading on NYSE, Scotts Miracle-Gro shares decreased by 0.4 percent to $63.00 [4]